CellWell record HH-329687
Comprehensive analysis of complement activation in a hydroxyurea-treated patient cohort with sickle cell disease
Daniel Diatlov; Arlette Bohorquez-Hernandez; Melanie Kirby-Allen; Christoph Licht
2026
In plain language
Hydroxyurea-treated patients with sickle cell disease showed attenuated complement activation despite elevated heme, with peak activity in early vaso-occlusive crisis.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-329687
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.